Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Patients and data tracking

How we applied user-led design thinking in the ER setting to improve patient care

The challengeOur client needed to identify the key delivery-device attributes for an antibiotic topical treatment used to combat a group of infections typically affecting young children. Current treatment is a...

Inizio

Research conducted by Research Partnership published in leading medical journal

Findings from a study conducted by Research Partnership have recently been published in the ‘Supportive Care in Cancer’ journal

Inizio

- PMLiVE

Theratechnologies’ last-ditch HIV drug approved by FDA

The injectable becomes an add-on treatment for patients who have previously taken ART

- PMLiVE

Luis Iglesias heads Santen EMEA

His promotion sees him succeed Shigeo Taniuchi

José Baselga joins BMS’ board of directors

He will serve as a member of the science and technology committee

Bristol-Myers Squibb (BMS) building

BMS gets OK for monthly Opdivo dosing

Analysts predict the new dosing schedule could see the pharma giant win market share

- PMLiVE

Diagnostics firm Diaceutics signs AI collaboration with Lenovo and Intel

Will use artificial intelligence to improve cancer outcomes

Otsuka rewards digital health startup NeuroFlow

Mental illness tech platform wins the pharma firm's US pitch challenge

Digital shakeout

Recent announcements by Nokia, Roche and others point to where digital health is heading

The Lucid Festival of Magic

Lucid Group threw a spellbinding event to celebrate eleven years of transforming lives with their standout new branding taking centre stage.

Lucid Group Communications Limited

Periodic Table of Healthcare Communications 2018

The Periodic Table of Healthcare Communications 2018

The definitive framework for building healthcare communication strategies and plans. Covering Brand Planning, Customer Experience and Multi-channel Marketing.

An agency called Owen

Gilead Sciences

Gilead says switching studies back new HIV therapy Biktarvy

Patients who switched from rival Triumeq could maintain viral suppression over the trial period

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links